As expected, no word yet on who’s going to be occupying the White House for the next four years. A little more surprising was the market’s reaction to the fact that Washington gridlock will continue. But the worst could still be yet to come…
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
With GameStop plummeting back to Earth this week, gangs of traders are on the lookout for the next potential squeeze target. That’s what’s driving today’s massive surge in shares your rare disease biotech play...
As I mentioned yesterday, SRAC didn’t get the votes it needed to extend its merger timeline with Momentus. So if you haven’t put in your vote yet, you need to do that ASAP. Your profits depend on it.
In today’s exclusive event, I’ll be breaking down my favorite new way to profit from Apple’s highly anticipated iPhone event tomorrow. (More on that in a moment.) I’ll also go over your Catalyst Calendar, which covers 12 special upcoming catalyst dates I’m watching for potential trades. And I’ve invited some of my top colleagues to join me for the Symposium.
Santa might be leaving us a little something extra in our stocking this year — one more catalyst looks close to triggering before the new year…
Last week, we added a new biotech name to the portfolio. Today, I want to share an exciting update on your other clinical-stage biotech play.
Some truly exciting trends are emerging in our Catalyst Trader portfolio! Today, I want to provide you with some longer-form updates than the standard weekly one-liner, plus a look ahead at upcoming catalysts I’m monitoring on our calendar.